Rhythmia Medical, a Burlington, MA-based maker of catheter-based systems for mapping the heart, has brought in $5 million of a planned $7 million equity offering, according to an SEC filing. The financing comes from eight investors, according to the filing, and brings Rhythmia’s total funding pot to $17 million. Earlier this spring, Ryan wrote about the startup’s plans to raise more capital to put towards the quest for regulatory approval and commercialization of its device, which is designed to form a 3D image of the heart in order to target the tissues responsible for irregular heartbeats.
Author: Erin Kutz
Erin Kutz has a background in covering business, politics and general news. She holds a bachelor’s degree in journalism from Boston University. Erin previously worked in the Boston bureau of Reuters, where she wrote articles on the investment management and mutual fund industries. While in college, she researched for USA Today reporter Jayne O’Donnell’s book, Gen Buy: How Tweens, Teens and Twenty-Somethings Are Revolutionizing Retail. She also spent a semester in Washington, DC, reporting Capitol Hill stories as a correspondent for two Connecticut newspapers and interning in the Money section of USA Today, where she assisted with coverage on the retail and small business beats. Erin got her first taste of reporting at Boston University’s independent student newspaper, as a city section reporter and fact checker and editor of the paper’s weekly business section.
View all posts by Erin Kutz
